Copertina

Prenatal Screening Via cfDNA – Paired‐End Sequencing Utilizing Fragment Size Information Reduces the Screen Positive Rate for X Chromosome Aneuploidies

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Susan Hancock, Franchesca Liao, Theresa Boomer, Sung Kim, Eileen de Feo
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Prenatal Diagnosis
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Correspondence on “Current Controversy in Prenatal Diagnosis: The Use of cfDNA to Screen for Monogenic Conditions in Low Risk Populations Is Ready for Clinical Use”
di: Julia Wynn, et al.
Pubblicazione: (2024)

Persistent Uninterpretable or Failed Prenatal Cell‐Free DNA Screening Indicates a High‐Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA‐Analysis: A Prospective Cohort Study
di: L. Lannoo, et al.
Pubblicazione: (2025)

Performance of Prenatal Cell‐Free DNA Screening for Foetal Chromosome Aneuploidies and Microdeletion/Microduplication Syndromes: A Retrospective Study of 64,482 Consecutive Cases From a Prenatal Diagnosis Centre in China
di: Feiyan Pan, et al.
Pubblicazione: (2025)

Clinical Utility of Nuchal Translucency Measurement in First‐Trimester Ultrasound Screening in a Setting With First‐Tier NIPT for Aneuploidy Screening
di: Eline E. R. Lust, et al.
Pubblicazione: (2025)

Screening Positive for Rare Autosomal Aneuploidies Increases Frequency of Adverse Pregnancy Outcomes and Alters Clinical Management
di: Devika Chawla, et al.
Pubblicazione: (2025)

Combined Cell‐Free DNA Screening for Aneuploidies and Selected Single‐Gene Disorders for Pregnancies With Sonographically Detected Fetal Anomalies: Detection Rate and Residual Risk
di: Thi Lan Anh Luong, et al.
Pubblicazione: (2024)

Improving the Performance of Prenatal Cell‐Free DNA Screening Through Size‐Selective Fetal DNA Enrichment in a Cohort of 71,986 General and High‐Risk Pregnancies
di: Liang Hu, et al.
Pubblicazione: (2025)

Prenatal Diagnosis of Sotos Syndrome: Integrating Chromosomal Microarray Analysis and Exome Sequencing
di: Xi Yang, et al.
Pubblicazione: (2025)

Quality of Evidence for Prenatal Down Syndrome Screening: An Umbrella Review
di: Yuehua Zhang, et al.
Pubblicazione: (2026)

‘I Could Trust It’: Experiences of Reciprocal Translocation Carriers and Their Partners With Prenatal Cell‐Free DNA Screening for Unbalanced Translocations
di: Marta Cifuentes Ochoa, et al.
Pubblicazione: (2024)

Disparities in Prenatal Carrier Screening Including Partner Testing by Insurance Status
di: Spencer C. Darveau, et al.
Pubblicazione: (2026)

Theoretical Performance of Comprehensive Non‐Invasive Prenatal Screening in Congenital Heart Defects
di: Emily Yang, et al.
Pubblicazione: (2026)

Artifacts, Not Differences in Sex Development, Are the Predominant Cause of Phenotypic Sex Discordance With Prenatal Cell‐Free DNA Screening: A Review of 33 Cases
di: Qiliang Ding, et al.
Pubblicazione: (2025)

Blazing the Trail of Non‐Invasive Prenatal Screening Expanded Use: Healthcare Providers' Perspectives
di: Tierry M. Laforce, et al.
Pubblicazione: (2025)

A Prospective Evaluation of the Diagnostic Utility for Low‐Coverage Genome Sequencing in Prenatal Samples: A Comparison With Chromosomal Microarray Analysis
di: Yan Yin, et al.
Pubblicazione: (2025)

Genome‐Wide Cell‐Free DNA Analysis for Aneuploidy Detection in Miscarriages: Test Performance Meta‐Analysis
di: Montse Pauta, et al.
Pubblicazione: (2025)

Prenatal Screening for Fetal X‐Linked Ichthyosis: A Large Cohort Study Combining Non‐Invasive Prenatal Testing and Maternal Serum Unconjugated Estriol Analysis
di: Miao Han, et al.
Pubblicazione: (2026)

Accurate Detection of Multiple Chromosome Rearrangements and Copy Number Variations by PacBio Sequencing in Complex Chromosomal Abnormality
di: Lili Liu, et al.
Pubblicazione: (2026)

How Are SNP‐Array, Karyotyping, and FISH Applied in Prenatal Practice? A Focus on Diagnosis of Mosaicism Involving the Sex Chromosomes
di: Xiaojin Luo, et al.
Pubblicazione: (2026)

The Intersection Between Genetic Reproductive Carrier Screening and Genomic Newborn Screening: Implications for Clinical Practice
di: Lilian Downie, et al.
Pubblicazione: (2025)

Diagnostic Yield After Postnatal Reanalysis of Prenatal Exome Sequencing Results
di: Kate Swanson, et al.
Pubblicazione: (2025)

The Arrival of Exome Sequencing in French Prenatal Diagnosis: An Exploratory Qualitative Study Among Professionals in Prenatal Diagnosis Centers: Prenatome‐SHS
di: Charlène Daval, et al.
Pubblicazione: (2025)

The Perspectives and Experiences of Prospective Parents Declining Diagnostic Prenatal Genome Sequencing in Continuing Pregnancies With Fetal Structural Anomalies
di: Lisa S. Weingarten, et al.
Pubblicazione: (2025)

A Framework for Bioinformatic Reporting in Prenatal Sequencing: Insights From a Systematic Review
di: Ashley J. Pritchard, et al.
Pubblicazione: (2026)

Diagnostic Yield of Sequencing for Prenatal Diagnosis of Fetal Structural Anomalies: An Updated Systematic Review
di: Karen Mei Xian Lim, et al.
Pubblicazione: (2026)

Clinical and Molecular Features of Ciliopathies Diagnosed by Prenatal Exome Sequencing in Fetuses With Ultrasound Abnormalities
di: Xiaofan Zhu, et al.
Pubblicazione: (2025)

Brain Abnormalities in Prenatally Diagnosed Rubinstein‐Taybi Syndrome
di: Laurence S. Carmant, et al.
Pubblicazione: (2025)

Exome Sequencing in Prenatally Diagnosed Isolated Neural Tube Defects: A Subtype‐Specific Analysis
di: Adi Botvinik, et al.
Pubblicazione: (2026)

Use of Prenatal Exome Sequencing: Opinion Statement of the French Federation of Human Genetics Working Group
di: Guillaume Cogan, et al.
Pubblicazione: (2024)

Monocentric Study on the Performance of Noninvasive Prenatal Testing on Cell‐Free DNA for the Detection of Monosomy X
di: Kelly Steinfort, et al.
Pubblicazione: (2024)

Prenatal Ultrasound Features of Biliary Atresia: Diagnostic Significance of Abnormal Gallbladder Size and Hepatic Hilar Cyst
di: Wu Xu, et al.
Pubblicazione: (2025)

Genome Sequencing for All Pregnant Persons: Navigating the Next Frontier in Prenatal Diagnosis Through Patient Reflections
di: Kristen E. Kelly, et al.
Pubblicazione: (2025)

Whole Genome Sequencing in Prenatal Diagnostics: The Danish Approach to Guideline Formation and Implementation Within Public Healthcare
di: Ida Vogel, et al.
Pubblicazione: (2025)

Reassurance‐Focused First‐Trimester Euploidy Screening With Machine Learning
di: Paula Idalia Szenejko, et al.
Pubblicazione: (2026)

Low‐Pass Genome Sequencing Reveals Associations Between Chromosomal Aberrations and Ultrasonographic Anomalies in a Cohort of 19,452 Fetuses
di: Lijuan Pan, et al.
Pubblicazione: (2026)

Is It Feasible to Screen for Fetal De Novo or Paternally Inherited Pathogenic Single Nucleotide Variants in Maternal Plasma Cell‐Free DNA? A Systematic Literature Review
di: Kristína Valovičová, et al.
Pubblicazione: (2025)

Prenatal Exome Sequencing Analysis in Fetuses With Structural Anomalies: A Multicenter Prospective Cohort Study With Practical Implications
di: Yulin Jiang, et al.
Pubblicazione: (2025)

Type 0 Spinal Muscular Atrophy Detected by Prenatal Exome Sequencing: Towards a Recognizable Fetal Phenotype
di: M. Codina‐Solà, et al.
Pubblicazione: (2026)

Screening and Predictive Biomarkers for Down Syndrome Through Amniotic Fluid Metabolomics
di: Li‐Chao Zhang, et al.
Pubblicazione: (2024)

Diagnostic Value of Cell‐Free DNA Fetal Fraction in Patients With Prenatally Suspected Placenta Accreta Spectrum Disorder
di: Danielle Chirumbole, et al.
Pubblicazione: (2025)